- Glaukos Corporation Announces Second Quarter 2022 Financial Results
- Glaukos Announces FDA 510(k) Clearance of iStent infinite®
- Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3
- Glaukos Announces Participation in the William Blair Growth Stock Conference
- Chau Khuong Joins Catalio Capital Management as General Partner
- Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium
Glaukos Corp (GKOS:NYQ) closed at 52.73, -18.24% below its 52-week high of 64.49, set on Apr 08, 2022.
33.33May 10 202264.49Apr 08 2022
Markit short selling activity
|Market cap||2.40bn USD|
|EPS (TTM)||-1.19 |
Data delayed at least 15 minutes, as of Aug 15 2022 21:10 BST.